ALKemist Bio

Private

TurinHealthcare & Life Scienceshttps://www.alkemistbio.com/

Last Round

Seed

Dec 21, 2023

Total Funding Raised

$7.56M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ALKemist Bio is a biotechnology company developing T-cell receptor (TCR-T) cell therapies for ALK-positive cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cellular immunotherapyCAR-T therapyTCR-T therapyadoptive cell therapyautologous cell therapyimmuno-oncologyALK-positive cancerALK targeted therapynon-small cell lung cancerNSCLCneuroblastomagene therapytreatment-resistant cancerpreclinical biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ALKemist Bio Comparables

Compare ALKemist Bio with similar companies based on industry and business-model similarity.

ALKemist Bio comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

ALKemist Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Dec 21, 2023

View all Funding Rounds

ALKemist Bio Investors

Notable investors and investment history

ALKemist Bio investors
Investor	Rounds
Club degli Investitori	Seed
Claris Ventures	Seed
Simon Fiduciaria	Seed
LIFTT EuroInvest	Seed
Italian Angels for Growth	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 15, 2026
Monthly visitors increased 2217% MoM, reaching 1.5K.
Jun 1, 2025
Monthly visitors grew 65% MoM, reaching 1.2K.

View all signals

ALKemist Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ALKemist Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ALKemist Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersTurin

Employee Range6

Year Founded2023

Last FundingDec 21, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.